TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

IP Theft? China's Tougher Patent Law Brings Payouts, Pharma Dispute Fix
Play
INVESTING

TG Therapeutics Soars on Positive Results for MS Treatment

  • By Rob Lenihan
  • Dec 10, 2020 2:24 PM EST
IP Theft? China's Tougher Patent Law Brings Payouts, Pharma Dispute Fix
INVESTING

TG Therapeutics Soars on Positive Results for MS Treatment

  • By Rob Lenihan
  • Dec 10, 2020 2:24 PM EST
PRESS RELEASES

Canadians Living With Multiple Sclerosis Find Support During COVID-19 Pandemic Through Dedicated Social Media Network

  • By PR Newswire
  • Dec 8, 2020 10:00 AM EST
Fosun Hopes To Launch BioNTech And Pfizer's Covid-19 Vaccine In China At The Same Time As US And Europe, Guo Guangchang Says
Video

EU and U.S. Working With Moderna and BioNTech on Vaccine Rollout

  • Nov 20, 2020 10:05 AM EST
18 vaccine sh
INVESTING

Moderna and BioNTech Looking at Imminent EU Vaccine Approval

  • By M. Corey Goldman
  • Nov 20, 2020 10:06 AM EST
Regeneron Lead
INVESTING

Regeneron Posts Better-Than-Expected Third-Quarter Earnings

  • By M. Corey Goldman
  • Nov 5, 2020 9:42 AM EST
Hong Kong And China Stocks Fall After Federal Reserve Warns On Stimulus To Support Recovery, Pandemic Resurgence
JIM CRAMER

Small Biz Needs Help: Cramer's 'Mad Money' Recap (Thursday 9/24/20)

  • By Bret Kenwell
  • Sep 24, 2020 8:43 PM EDT
PRESS RELEASES

(PRNB) Alert: Johnson Fistel Investigates Proposed Sale Of Principia Biopharma; Is $100 A Fair Price?

  • By PR Newswire
  • Sep 12, 2020 8:40 AM EDT
AstraZeneca Lead
INVESTING

AstraZeneca Shares Fall After COVID-19 Vaccine Study Placed on Hold

  • By Tom Bemis
  • Sep 8, 2020 7:05 PM EDT
PRESS RELEASES

Biopharma Leaders Unite To Stand With Science

  • By GlobeNewswire
  • Sep 8, 2020 6:30 AM EDT
Coronavirus Masks Social Distance Lead
Video

Coronavirus Update: Vaccine News From Sanofi and Novovax

  • Sep 3, 2020 8:47 AM EDT
Novavax Lead
INVESTING

Novavax Gains Following Promising Covid-19 Vaccine Trials

  • By M. Corey Goldman
  • Sep 3, 2020 9:35 AM EDT
Sanofi Lead
INVESTING

Sanofi Fast-Tracking Covid-19 Vaccine to Human Trials

  • By M. Corey Goldman
  • Sep 3, 2020 9:37 AM EDT
Sanofi Lead
INVESTING

Sanofi Arthritis Drug Fails as Possible Coronavirus Treatment

  • By Rob Lenihan
  • Sep 1, 2020 10:04 AM EDT
Moderna Lead
INVESTING

Moderna in Talks to Supply Japan With 40 Million Covid Vaccine Doses

  • By M. Corey Goldman
  • Aug 28, 2020 9:53 AM EDT
Hong Kong Third Wave: Finance Chief Warns Of New Coronavirus Blow For Businesses
STOCKS

VBI Vaccines Shares Soar on Covid-19 Candidates, Upgrade

  • By Rob Lenihan
  • Aug 27, 2020 3:15 PM EDT
PRESS RELEASES

PRINCIPIA ALERT: Bragar Eagel & Squire, P.C. Investigates Sale Of PRNB And Encourages Investors To Contact The Firm

  • By Business Wire
  • Aug 17, 2020 1:35 PM EDT
PRESS RELEASES

(PRNB) Alert: Johnson Fistel Investigates Proposed Sale Of Principia Biopharma; Is $100 A Fair Price?

  • By PR Newswire
  • Aug 17, 2020 8:37 AM EDT
Buy Drug Maker Sanofi After It Surpassed Third-Quarter Estimates
INVESTING

Sanofi to Acquire U.S. Biotech Principia Biopharma for $100 a Share

  • By Joseph Woelfel
  • Aug 17, 2020 5:45 AM EDT
Wake Up Wall Street: Markets Cautious Ahead of Trump's China Meeting
MARKETS

Dow Futures, Barrick Gold, Sanofi, Principia Biopharma - 5 Things You Must Know Monday

  • By Joseph Woelfel
  • Aug 17, 2020 7:58 AM EDT
Novavax Lead
Video

Novavax and J&J Are Getting The Royal Treatment

  • Aug 14, 2020 9:58 AM EDT
CureVac Lead
IPOs

CureVac Triples in Nasdaq Public Debut

  • By M. Corey Goldman
  • Aug 14, 2020 12:59 PM EDT
11. Vaccinations
INVESTING

Novavax and Johnson & Johnson to Supply U.K. With Covid-19 Vaccines

  • By M. Corey Goldman
  • Aug 14, 2020 10:04 AM EDT
Jim Cramer: Johnson & Johnson Will Do Well With Actelion
INVESTING

Johnson & Johnson, EU Complete Exploratory Talks for Vaccine

  • By Dan Weil
  • Aug 13, 2020 2:10 PM EDT
Coronavirus: Chinese Pharmaceutical Firm Says Covid-19 Vaccine May Be Ready This Year
Video

Sanofi and Glaxo Get 'Operation Warp Speed' Covid-19 Funding

  • Jul 31, 2020 10:59 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.